Healthcare


 Groundbreaking Advancements: Prescient Therapeutics (ASX:PTX) Launches Phase 2a Trial for Novel CTCL Therapy

Groundbreaking Advancements: Prescient Therapeutics (ASX:PTX) Launches Phase 2a Trial for Novel CTCL Therapy

March 26, 2025 02:30 PM AEDT| By Team Kalkine Media

Highlights,Prescient Therapeutics (,ASX:PTX,) has,initiated,a Phase 2a study of PTX-100.,The study will evaluate the efficacy and safety of PTX-100 in CTCL patients.,Sites across Australia, the USA, and Europe are set to,participate,.,Prescient Thera...

 LTR Pharma Expands into the U.S. Market with Roxus Nasal Spray

LTR Pharma Expands into the U.S. Market with Roxus Nasal Spray

March 26, 2025 02:30 PM AEDT| By Team Kalkine Media

LTR Pharma Expands into the U.S. Market with Roxus Nasal Spray

 Orthocell Expands Striate+ Sales into DACH Region Amid Growing Global Demand

Orthocell Expands Striate+ Sales into DACH Region Amid Growing Global Demand

March 26, 2025 12:00 AM AEDT| By Team Kalkine Media

Highlight:,Striate+ enters Germany, Austria, and Switzerland following strong EU and UK traction,Distribution partner BioHorizons Camlog initiates first sales in the DACH region,Clinical success and surgeon feedback underpin rapid global expansion st...

 Clinuvel's Stroke Treatment Study Shows Promising Results

Clinuvel's Stroke Treatment Study Shows Promising Results

March 26, 2025 12:00 AM AEDT| By Team Kalkine Media

Highlights,Significant functional improvement observed in stroke trial participants.,Majority show positive radiological outcomes.,Clinuvel (CUV) optimistic about afamelanotide's safety and effectiveness.,Clinuvel (ASX:CUV) recently announced encoura...

 Streamlining for Success: 4DMedical Limited (ASX:4DX) Launches Major Cost Reduction Initiative

Streamlining for Success: 4DMedical Limited (ASX:4DX) Launches Major Cost Reduction Initiative

March 26, 2025 12:00 AM AEDT| By Team Kalkine Media

Highlights,Substantial Cost Cuts:,4DMedical Limited (4DX) announces $6.5 million in annual savings.,Financial Resilience:,Despite cost cuts, the company maintains a strong financial outlook with significant capital from recent funding rounds.,Leaders...

 LTR Pharma (ASX:LTP) Expands Horizons with FDA Endorsement and New Product Launch

LTR Pharma (ASX:LTP) Expands Horizons with FDA Endorsement and New Product Launch

March 26, 2025 12:00 AM AEDT| By Team Kalkine Media

Highlights,LTR Pharma secures FDA endorsement for SPONTAN® development.,Launch of Roxus® aims to tap into the US personalized healthcare market.,SPONTAN® earns scientific accolades for rapid absorption and efficacy.,LTR Pharma Limited (ASX:LTP) is ma...

 Orthocell Pioneers Expansion with Striate+ in Central Europe

Orthocell Pioneers Expansion with Striate+ in Central Europe

March 26, 2025 12:00 AM AEDT| By Team Kalkine Media

Highlights,Orthocell (OCC) marks its first sales of Striate+ in the DACH region.,Positive clinical outcomes boost the product's market acceptance.,Strong financials support strategic expansions into new markets.,Orthocell Limited (ASX:OCC) has succes...

 Expanding Horizons: Orthocell’s Striate+ Makes Groundbreaking Entry into European Markets

Expanding Horizons: Orthocell’s Striate+ Makes Groundbreaking Entry into European Markets

March 26, 2025 12:00 AM AEDT| By Team Kalkine Media

Highlights,Orthocell (ASX: OCC) ventures into Germany, Austria, and Switzerland with Striate+.,Significant revenue potential eyed with a targeted market share in a billion-dollar industry.,Positive feedback and high success rates propel demand for in...

 Vanguard's Latest US Market ETF Distribution: Key Dates and Details

Vanguard's Latest US Market ETF Distribution: Key Dates and Details

March 26, 2025 12:00 AM AEDT| By Team Kalkine Media

Highlights,Final distribution announced for (ASX:VTS) holders.,Key dates from ex-distribution to payment detailed.,Important information on CDI cancellation requests.,Vanguard Investments Australia Ltd recently announced a final distribution for the...

 ASX Stocks Gaining Attention Amid Market Fluctuations

ASX Stocks Gaining Attention Amid Market Fluctuations

March 25, 2025 05:56 PM AEDT| By Team Kalkine Media

ASX Stocks Gaining Attention Amid Market Fluctuations

 Immutep makes progress with first lung cancer patient dosing

Immutep makes progress with first lung cancer patient dosing

March 25, 2025 03:31 PM AEDT| By Team Kalkine Media

Immutep makes progress with first lung cancer patient dosing

 Aroa Biosurgery (ARX) Is Well-Positioned for Business Growth

Aroa Biosurgery (ARX) Is Well-Positioned for Business Growth

March 25, 2025 03:31 PM AEDT| By Team Kalkine Media

Aroa Biosurgery (ARX) Is Well-Positioned for Business Growth

 Immutep Limited (ASX:IMM) Launches Major Phase III Trial Targeting Lung Cancer

Immutep Limited (ASX:IMM) Launches Major Phase III Trial Targeting Lung Cancer

March 25, 2025 03:06 PM AEDT| By Team Kalkine Media

Highlights,Immutep Limited (IMM) begins pivotal Phase III trial for lung cancer treatment.,The global study aims to enroll over 750 patients in 25+ countries.,Potential for setting a new standard of care in treating advanced lung cancer.,In a signifi...

 Is Investing in Ramsay Health Care (RHC) Considered Risky?

Is Investing in Ramsay Health Care (RHC) Considered Risky?

March 24, 2025 01:32 PM AEDT| By Team Kalkine Media

Is Investing in Ramsay Health Care (RHC) Considered Risky?

 Beamtree Expands Automation in Clinical Coding

Beamtree Expands Automation in Clinical Coding

March 24, 2025 01:30 PM AEDT| By Team Kalkine Media

Beamtree Expands Automation in Clinical Coding

 Opthea's Phase 3 trial results fall short in aiding patients, putting the company's future in jeopardy.

Opthea's Phase 3 trial results fall short in aiding patients, putting the company's future in jeopardy.

March 24, 2025 01:30 PM AEDT| By Team Kalkine Media

Opthea's Phase 3 trial results fall short in aiding patients, putting the company's future in jeopardy.

 Clinical Trials and Technological Innovations: A Mixed Landscape

Clinical Trials and Technological Innovations: A Mixed Landscape

March 24, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Opthea's eye disease trial fails to meet primary endpoints, casting doubts on its future.,HitIQ partners with a major Australian amateur league, aiming to improve concussion detection.,Telix receives FDA approval, extending its prostate ca...

 Opthea Seeks Lifeline After Clinical Setback, Suspends Trading to Regroup

Opthea Seeks Lifeline After Clinical Setback, Suspends Trading to Regroup

March 24, 2025 12:00 AM AEDT| By Team Kalkine Media

Highlights,Opthea pauses trading as it explores funding options,Clinical trial for OPT-302 misses key target,Future of wet-AMD treatment strategy under review,Opthea (ASX:OPT) has entered a critical phase in its development journey, as trading of its...

 Austco Healthcare's Impressive Growth Journey

Austco Healthcare's Impressive Growth Journey

March 22, 2025 05:30 PM AEDT| By Team Kalkine Media

Highlights,Austco Healthcare's share price soared 455% over five years.,The company achieved a total shareholder return of 478% over the same period.,Recent insider buying suggests potential confidence in future growth.,Investors have often been on t...

 Trajan Group's Innovative Ventures and Global Strategy

Trajan Group's Innovative Ventures and Global Strategy

March 22, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Trajan Group's micro blood sampling tools are influencing both terrestrial and space applications, providing precise samples in even the most remote locations.,The company is at the forefront of detecting 'forever chemicals' and impurities...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.